Procter & Gamble Co (NYSE:PG) Shares Sold by Abner Herrman & Brock LLC

Share on StockTwits

Abner Herrman & Brock LLC cut its position in Procter & Gamble Co (NYSE:PG) by 3.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,238 shares of the company’s stock after selling 437 shares during the period. Abner Herrman & Brock LLC’s holdings in Procter & Gamble were worth $1,771,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Krane Funds Advisors LLC purchased a new stake in Procter & Gamble in the second quarter valued at $25,000. Lucia Wealth Services LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at $29,000. Camarda Financial Advisors LLC grew its stake in shares of Procter & Gamble by 59.2% in the second quarter. Camarda Financial Advisors LLC now owns 269 shares of the company’s stock valued at $29,000 after buying an additional 100 shares in the last quarter. Dougherty Wealth Advisers LLC grew its stake in shares of Procter & Gamble by 250.0% in the second quarter. Dougherty Wealth Advisers LLC now owns 350 shares of the company’s stock valued at $38,000 after buying an additional 250 shares in the last quarter. Finally, Princeton Global Asset Management LLC grew its stake in shares of Procter & Gamble by 51.4% in the second quarter. Princeton Global Asset Management LLC now owns 442 shares of the company’s stock valued at $48,000 after buying an additional 150 shares in the last quarter. 65.62% of the stock is currently owned by hedge funds and other institutional investors.

In other news, VP Valarie L. Sheppard sold 17,000 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $120.20, for a total value of $2,043,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Carolyn M. Tastad sold 10,662 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $118.00, for a total value of $1,258,116.00. Following the completion of the sale, the insider now directly owns 61,225 shares of the company’s stock, valued at $7,224,550. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 448,674 shares of company stock valued at $53,197,461. Insiders own 1.75% of the company’s stock.

Shares of NYSE:PG traded down $0.39 on Friday, hitting $121.55. 238,095 shares of the company’s stock were exchanged, compared to its average volume of 6,660,306. The firm’s 50-day moving average is $121.79 and its 200 day moving average is $112.57. The company has a market capitalization of $302.64 billion, a PE ratio of 26.88, a P/E/G ratio of 3.51 and a beta of 0.42. Procter & Gamble Co has a 1-year low of $78.49 and a 1-year high of $125.36. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.06 by $0.04. The business had revenue of $17.09 billion during the quarter, compared to analysts’ expectations of $16.86 billion. Procter & Gamble had a return on equity of 23.03% and a net margin of 5.76%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.94 EPS. On average, analysts anticipate that Procter & Gamble Co will post 4.85 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.7459 per share. The ex-dividend date of this dividend is Thursday, October 17th. This represents a $2.98 annualized dividend and a dividend yield of 2.45%. Procter & Gamble’s dividend payout ratio is currently 65.93%.

A number of equities research analysts have recently weighed in on PG shares. Stifel Nicolaus set a $117.00 price objective on Procter & Gamble and gave the company a “hold” rating in a research note on Wednesday, July 31st. TheStreet cut Procter & Gamble from an “a-” rating to a “c+” rating in a research note on Tuesday, July 30th. SunTrust Banks boosted their target price on Procter & Gamble to $120.00 and gave the stock a “hold” rating in a research note on Wednesday, July 31st. Credit Suisse Group boosted their target price on Procter & Gamble from $108.00 to $117.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 31st. Finally, Royal Bank of Canada reissued a “neutral” rating and set a $89.00 target price on shares of Procter & Gamble in a research note on Tuesday, July 30th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have assigned a buy rating to the stock. Procter & Gamble currently has an average rating of “Hold” and a consensus price target of $108.95.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Featured Story: Profit Margin

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.